Cryptosporidium Parvum/Hominis Test

Cryptosporidium parvum (C. parvum) and Cryptosporidium hominis (C. hominis) are microscopic protozoan parasites that infect the small intestine. They spread by the fecal-oral route, most often through contaminated water or food, or close contact with infected people or animals. Their infectious form, the oocyst, is a tough, spherical capsule shed in stool. Oocysts resist chlorine used in standard water treatment and remain infectious in the environment, which explains why community and recreational water outbreaks occur. C. hominis primarily infects humans and is often linked to person-to-person spread, while C. parvum infects both humans and animals and is a common source of zoonotic transmission from livestock. Infection typically causes watery diarrhea, cramping, nausea, and weight loss. Illness is usually self-limited in healthy adults, but it can be prolonged and dangerous in young children and in people with weakened immunity, such as advanced HIV or transplant recipients.

Diagnosis starts with stool testing. Microscopy with special stains can show the acid-fast oocysts but may miss low-level shedding. Antigen tests detect parasite proteins and are more sensitive than microscopy. PCR uses polymerase chain reaction to amplify parasite DNA, which makes it the most sensitive option and the best at identifying the species involved. Cryptosporidium parvum / hominis PCR confirms parasite DNA in stool and distinguishes whether infection is due to C. parvum or C. hominis. This matters clinically and for public health because species point to different transmission routes: human-to-human for C. hominis and animal-to-human for many C. parvum infections. PCR can also subtype strains by targeting genes like gp60, helping trace outbreaks and link cases to sources. Because oocyst shedding can be intermittent, collecting stool on more than one day improves detection. A positive PCR establishes infection or recent infection, and results should be interpreted alongside symptoms and immune status. In immunocompetent patients, treatment is mainly hydration plus nitazoxanide, the only approved antiparasitic. In immunocompromised patients, restoring immune function is central because nitazoxanide has limited benefit. Prevention focuses on safe water, effective filtration or boiling, meticulous hand hygiene, and avoiding high-risk animal exposures.